共 541 条
[1]
Wollina U(2012)Pityriasis rubra pilaris Hautarzt 63 655-61
[2]
Artik S(2004)Pityriasis rubra pilaris Hautarzt 55 980-3
[3]
Kuhn A(2016)Erythrodermic pityriasis rubra pilaris: dramatic response to infliximab therapy Indian J Dermatol Venereol Leprol 82 112-7
[4]
Neumann NJ(2016)Erythematosquamous dermatoses in adolescence Hautarzt 67 293-11
[5]
Ruzicka T(1999)Pityriasis rubra pilaris Int J Dermatol 38 1-12
[6]
Megahed M(1980)Pityriasis rubra pilaris Clin Exp Dermatol 5 105-5
[7]
Karadag AS(2012)Pityriasis rubra pilaris: treatment with biologics — a new promising therapy? Dermatology 224 120-5
[8]
Kavala M(2016)Epidemiologic, clinicopathologic, diagnostic, and management challenges of pityriasis rubra pilaris: a case series of 100 patients JAMA Dermatol 152 670-85
[9]
Ozlu E(2011)Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index
[10]
Ozkanli S(2001)Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids J Biol Chem 276 42714-35